Is SYNH undervalued or overvalued?
As of 2025-04-18, the Intrinsic Value of Syneos Health Inc (SYNH) is 79.07 USD. This SYNH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 42.98 USD, the upside of Syneos Health Inc is 84.00%. This means that SYNH is undervalued by 84.00%.
The range of the Intrinsic Value is 47.03 - 171.23 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 47.03 - 171.23 | 79.07 | 84.0% |
| DCF (Growth 10y) | 60.96 - 195.97 | 96.07 | 123.5% |
| DCF (EBITDA 5y) | 63.74 - 76.43 | 69.48 | 61.7% |
| DCF (EBITDA 10y) | 79.02 - 103.96 | 90.31 | 110.1% |
| Fair Value | 17.17 - 17.17 | 17.17 | -60.06% |
| P/E | 14.46 - 73.14 | 42.00 | -2.3% |
| EV/EBITDA | 42.53 - 62.36 | 48.19 | 12.1% |
| EPV | 46.45 - 74.35 | 60.40 | 40.5% |
| DDM - Stable | 4.88 - 14.28 | 9.58 | -77.7% |
| DDM - Multi | 35.10 - 82.19 | 49.46 | 15.1% |
| Market Cap (mil) | 4,457.89 |
| Beta | 2.29 |
| Outstanding shares (mil) | 103.72 |
| Enterprise Value (mil) | 7,081.09 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.09% |
| Cost of Debt | 4.67% |
| WACC | 7.62% |